Life ScienceCompany
Jazz Pharmaceuticals has acquired 6 companies, including 2 in the last 5 years. A total of 3 acquisitions came from private equity firms. It has also divested 2 assets.
Jazz Pharmaceuticals’ largest acquisition to date was in 2021, when it acquired GW Pharmaceuticals for $6.7B. It’s largest disclosed sale occurred in 2022, when it sold Jazz Pharmaceuticals - Sunosi to Axsome Therapeutics for $53M. Jazz Pharmaceuticals has acquired in 4 different US states, and 3 countries. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to Jazz Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity8
- M&A Buy Activity6
- M&A Sell Activity2
- Total Sectors Invested 1
- Total Countries Invested 3
- M&A Buy/Sell Connections 5
- M&A Advisors 8
Unlimited Searches
